Axsome Shares Up 20% in a Month: How Should You Play the Stock?

Key Takeaways Axsome stock jumped 20.2% in a month, far outpacing its industry, sector and the S&P 500.Auvelity sales hit $215.9M in H1 2025, up 82.3% year over year, driving the company's top-line.Sunosi adds to AXSM's revenue momentum while new migraine drug Symbravo is likely to diversify the portfolio.Axsome Therapeutics (AXSM) delivered a strong performance over the past month, with its shares rallying 20.2% compared with the industry’s rise of 2.5%. The stock has also outperformed the sector and the S ...